AccuV: Intravenous Access Using Infrared Laser

• Sponsor: Centre Hospitalier Universitaire de Nīmes (Other)
• Overall Status: Completed
• CT.gov ID: NCT03555864
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Actual Duration (Months): 19.9
• Patients Per Site Per Month: 5

Study Details

Study Description

Brief Summary

Peripheral venous access is a prerequisite for anesthesiological for surgical patients.It is often difficult to establish and potentially painful in obese patients (Body mass Index > 35). AV300 uses near infrared laser light to improve visibility of peripheral veins and could help cannulating them. The aim of this study was to examine if use of Accuvein(®) AV300 vein viewer could facilitate venous cannulation in obese patients (surgical and obstetric).

Condition or Disease	Intervention/Treatment	Phase
Obesity, Morbid; Obstetric Anesthesia Problems	Device: infrared transluminescent device

Study Design

• Study Type: Observational
• Actual Enrollment: 100 participants
• Observational Model: Case-Crossover
• Time Perspective: Prospective
• Official Title: Peripheral Intravenous Cannulation With Support of Infrared Laser Vein Viewing System in Obese Patients
• Actual Study Start Date: Nov 6, 2017
• Actual Primary Completion Date: Nov 30, 2018
• Actual Study Completion Date: Jul 4, 2019

Arms and Interventions

Arm	Intervention/Treatment
Obese Patients need two intravenous access with infra red	Device: infrared transluminescent device; use of infra red for venous access for second intravenous access

Outcome Measures

Primary Outcome Measures

1. success for second intravenous line using infra red [1 day]

   number of attempts

Secondary Outcome Measures

1. time [1 day]

   time in second for second intravenous access

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 85 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria

• 18 years

• surgery that need double intravenous perfusion

Exclusion Criteria:

• < 18 years

• body mass index< 35

• refusal

• minor surgery that need only one intravenous access

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU Nimes	Nîmes	Gard	France	30 000

Sponsors and Collaborators

• Centre Hospitalier Universitaire de Nīmes

Investigators

• Study Chair: jean-yves Lefrant, MD,PhD, Centre Hospitalier Universitaire de Nīmes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Philippe Cuvillon, Clinical Professor, Centre Hospitalier Universitaire de Nīmes
• ClinicalTrials.gov Identifier: NCT03555864
• Other Study ID Numbers: Local-PC-2017-2
• First Posted: Jun 14, 2018
• Last Update Posted: Jul 8, 2019
• Last Verified: Jul 1, 2019

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Obesity, Morbid

Study Results

No Results Posted as of Jul 8, 2019